GOTHENBURG, Sweden, Oct. 24, 2019 /PRNewswire/ -- Oblique Therapeutics AB announces that Sreesha P Srinivasa is on the list of invited speakers who will be presenting at the RAS- Targeted Drug Discovery Europe Summit in Vienna in February 2020.Sreesha P Srinivasa, Senior Vice President at

New resources detail positive impact of aducanumab pivotal trial results and recent progress of ProMIS pipeline programs TORONTO and CAMBRIDGE, MA, Oct. 24, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of

CLEVELAND, Oct. 24, 2019 /PRNewswire/ -- Clinicians interested in learning more about MRI-guided radiation therapy can attend a day-long symposium on Friday, November 14, 2019 in Rome to understand the strategic, economic, clinical and technical aspects of starting an MR-image guided radiation therapy pr

Strong financials paving the way for broadening the business UPPSALA, Sweden, Oct. 24, 2019 Q3 2019 highlightsTotal net revenues of SEK 231.2 million (216.6), up 6.7 percent Zubsolv® US net revenues of SEK 182.7 million (165.4), up 10.4 percent in SEK and 3.0 p

STOCKHOLM, Oct. 24, 2019 /PRNewswire/ -- "We are now regaining the exclusive, global rights to develop and commercialize ADC-1013 and at the same time receive enough ADC-1013 substance to, with or without a new partner, bring ADC-1013 into Phase II clinical trials next year. In total, we now have three projects in clinical development, and soon another one where the f

OSLO, Norway, Oct. 24, 2019 /PRNewswire/ -- Reference is made to the stock exchange announcement on 18 October 2019 where Nordic Nanovector ASA (OSE: NANO) (the "Company") announced the successful completion of a private placement raising gross proceeds of NOK 242,525,624 (the "Private Placement") and that the b

MELBOURNE, Australia, Oct. 24, 2019 /PRNewswire/ -- A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol use disorder, according to researchers at the Florey Institute of Neuroscience and Mental Health.A world-first clinical study commenced between The Florey Institute and St Vincent's Hospital in

MEXICO CITY, Oct. 23, 2019 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), today announced its results for the second quarter ended June 30, 2019. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with In

PENCOED, Wales, Oct. 23, 2019 /PRNewswire/ -- ReNeuron Group plc (AIM: RENE),  a UK-based global leader in the development of cell-based therapeutics, is pleased to announce that new data relating to its CTX stem cell platform will be presented today at the 27th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT), a leading

PACIFICA, Calif., Oct. 23, 2019 /PRNewswire/ -- Lytt is the first and only licensed recreational cannabis business to open in San Mateo county. Located one block from the beautiful Pacifica Pier shoreline, Lytt is sure to become one of the most Premiere cannabis dispensaries on the Coast with its coastal vib